Johnson Financial Group Inc (Wisconsin)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.97K	Buy	63 +2	+3%	+$270	﹤0.01%	639
2026 Q1	$7.79K	Hold	61	–	–	﹤0.01%	657
2025 Q4	$7.44K	Sell	61 -312	-84%	-$35.8K	﹤0.01%	679
2025 Q3	$37.4K	Hold	373	–	–	﹤0.01%	646
2025 Q2	$30.9K	Buy	+373	New	+$29.8K	﹤0.01%	501
2024 Q4	–	Sell	-400	Closed	-$39.5K	–	1000
2024 Q3	$39.5K	Sell	400 -2,001	-83%	-$197K	﹤0.01%	542
2024 Q2	$223K	Buy	+2,401	New	+$215K	0.01%	307
2024 Q1	–	Sell	-2,936	Closed	-$262K	–	1003
2023 Q4	$262K	Buy	+2,936	New	+$218K	0.01%	266

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s XBI Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.3% in Q2 2026, buying an estimated $270 and bringing the position to 63 shares worth $9.97K. The position accounts for ﹤0.01% of the portfolio, ranked #639.

Johnson Financial Group Inc (Wisconsin) first reported a position in XBI in Q4 2023 and has held it in 8 quarters since. The position peaked at $262K in Q4 2023. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Johnson Financial Group Inc (Wisconsin) held 63 shares of State Street SPDR S&P Biotech ETF worth $9.97K as of Q2 2026.
Johnson Financial Group Inc (Wisconsin) bought 2 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $270.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #639 holding.
Johnson Financial Group Inc (Wisconsin) first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 8 quarters since.
Johnson Financial Group Inc (Wisconsin)'s State Street SPDR S&P Biotech ETF position peaked at $262K in Q4 2023.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.